Suppr超能文献

大鼠肾小球旁细胞具有介导肾素释放的DA-1多巴胺受体。

Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release.

作者信息

Kurtz A, Della Bruna R, Pratz J, Cavero I

机构信息

Physiologisches Institut, Universität Zürich, Switzerland.

出版信息

J Cardiovasc Pharmacol. 1988 Dec;12(6):658-63. doi: 10.1097/00005344-198812000-00006.

Abstract

Under control conditions a primary culture containing about 80-90% of granular juxtaglomerular (JG) cells prepared from rat kidneys continuously released renin into the culture medium at a rate of 17.9 +/- 1.4 ng angiotensin I/h per mg of cell proteins per 30 min (n = 14). Dopamine (1.0 microM), the DA-1 dopamine receptor agonist fenoldopam (0.5 microM), and isoproterenol (1.0 microM) increased renin secretion markedly (130-200%). Propranolol (0.1 microM) reduced the effects of isoproterenol significantly (80%), but not those of dopamine or fenoldopam. In contrast, SCH 23390 (0.01 microM), a DA-1 dopamine receptor antagonist, inhibited markedly only the renin release evoked by the latter two agonists, whereas S-sulpiride (10 microM), a DA-2 dopamine receptor antagonist, and phentolamine (10 microM), a nonselective alpha-adrenoceptor antagonist, did not modify the effects of either dopamine or fenoldopam. In rats, pithed to eliminate reflexogenic mechanisms regulating renin release, at the end of a 15 min i.v. infusion of fenoldopam (20 micrograms/kg per min) there was a significant increase in plasma renin activity. This effect was completely prevented by SCH 23390 (0.1 mg/kg i.v.) but not significantly changed by S-sulpiride (0.3 mg/kg i.v.) or phentolamine (3.0 mg/kg i.v.) plus propranolol (0.75 mg/kg i.v.). In conclusion, these results indicate that DA-1 dopamine receptors are present in rat kidney JG cells and that pharmacological stimulation of these receptors with dopamine or fenoldopam leads to renin secretion.

摘要

在对照条件下,由大鼠肾脏制备的含有约80 - 90%颗粒型球旁(JG)细胞的原代培养物,以每30分钟每毫克细胞蛋白17.9±1.4 ng血管紧张素I/小时的速率持续向培养基中释放肾素(n = 14)。多巴胺(1.0微摩尔)、DA - 1多巴胺受体激动剂非诺多泮(0.5微摩尔)和异丙肾上腺素(1.0微摩尔)显著增加肾素分泌(130 - 200%)。普萘洛尔(0.1微摩尔)显著降低异丙肾上腺素的作用(80%),但不影响多巴胺或非诺多泮的作用。相反,DA - 1多巴胺受体拮抗剂SCH 23390(0.01微摩尔)仅显著抑制后两种激动剂引起的肾素释放,而DA - 2多巴胺受体拮抗剂S - 舒必利(10微摩尔)和非选择性α - 肾上腺素能受体拮抗剂酚妥拉明(10微摩尔)不改变多巴胺或非诺多泮的作用。在大鼠中,通过脊髓切断以消除调节肾素释放的反射机制,在静脉输注非诺多泮(20微克/千克每分钟)15分钟结束时,血浆肾素活性显著增加。这种作用被SCH 23390(0.1毫克/千克静脉注射)完全阻断,但未被S - 舒必利(0.3毫克/千克静脉注射)或酚妥拉明(3.0毫克/千克静脉注射)加普萘洛尔(0.75毫克/千克静脉注射)显著改变。总之,这些结果表明大鼠肾脏JG细胞中存在DA - 1多巴胺受体,并且用多巴胺或非诺多泮对这些受体进行药理刺激可导致肾素分泌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验